Dr Camille Carroll
Dr Carroll is an academic consultant neurologist. Her research is focused on neuroprotection, and the use of digital health technologies for disease monitoring and personalized care in PD. Dr Carroll was the chief investigator of a multi-centre clinical trial of simvastatin as a neuroprotective agent in Parkinson’s disease (PD STAT). She co-leads the Edmond J Safra ACT-PD initiative, developing a multi-arm, multi-stage trial platform for neuroprotective interventions in Parkinson’s. She is the NIHR CRN National Specialty Lead for Neurodegenerative Diseases, overseeing a balanced clinical trial portfolio in neurodegenerative disorders, including Parkinson’s, Huntington’s, and motor neurone diseases. She leads the CRN Remote Trial Delivery working group and was a steering group member for NIHR Include. She leads the award-winning Parkinson’s service in Plymouth and has been internationally recognized for her patient centred work, broadening the opportunity for Parkinson’s research and improving support for patient care and self-management.
Dr Camille Carroll is a contributor to the following academies